SRRK insider transaction filings
Scholar Rock Holding Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-06. Screen SRRK transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | FLIER JEFFREY S. — Director | Sale (S): 1,568 @ $53.53 · Sale (S): 1,470 @ $54.24 · Sale (S): 15 @ $54.88 | EDGAR |
| 2026-07-06 | 4 | Reed Joshua — Director | Sale (S): 2,105 @ $53.50 · Sale (S): 948 @ $54.28 | EDGAR |
| 2026-07-06 | 4 | Peng Katie — Director | Sale (S): 2,988 @ $53.56 · Sale (S): 2,437 @ $54.25 · Sale (S): 21 @ $54.96 | EDGAR |
| 2026-07-06 | 4 | Burow Kristina — Director | Sale (S): 2,105 @ $53.49 · Sale (S): 948 @ $54.28 | EDGAR |
| 2026-07-06 | 4 | Gilman Michael — Director | Sale (S): 1,346 @ $53.54 · Sale (S): 1,155 @ $54.23 · Sale (S): 43 @ $54.81 | EDGAR |
| 2026-06-08 | 4 | FLIER JEFFREY S. — Director | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Reed Joshua — Director | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Peng Katie — Director | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Brudnick Richard — Director | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Burow Kristina — Director | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Gilman Michael — Director | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | AKKARAJU SRINIVAS — Director | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Burow Kristina — Director | Option exercise (M): 7,800 @ $26.78 · Option exercise (M): 28,000 @ $4.75 · Option exercise (M): 36,000 @ $9.11 · Option exercise (M): 18,000 @ $8.36 · Option exercise (M): 7,800 (derivative) @ $0 · Option exercise (M): 28,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-20 | 4 | Woods Keith — Chief Operating Officer | Sale (S): 10,220 @ $49.57 | EDGAR |
| 2026-04-20 | 4 | Vaishnaw Akshay — President of R&D, Director | Sale (S): 12,246 @ $49.57 | EDGAR |
| 2026-04-20 | 4 | Hallal David — Chief Executive Officer, Director | Sale (S): 30,615 @ $49.57 | EDGAR |
| 2026-04-20 | 4 | Sinha Vikas — Chief Financial Officer | Sale (S): 10,410 @ $49.57 | EDGAR |
| 2026-02-25 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Sale (S): 7,427 @ $46.94 · Sale (S): 857 @ $47.86 · Sale (S): 200 @ $48.48 | EDGAR |
| 2026-02-19 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Sale (S): 7,989 @ $46.53 | EDGAR |
| 2026-02-19 | 4 | Parlavecchio Caryn — CHRO | Sale (S): 9,035 @ $46.53 | EDGAR |
| 2026-02-19 | 4 | Ho Junlin — GENERAL COUNSEL | Sale (S): 9,580 @ $46.53 | EDGAR |
| 2026-02-19 | 4 | Marantz Jing L. — CHIEF MEDICAL OFFICER | Sale (S): 4,157 @ $46.53 | EDGAR |
| 2026-02-11 | 4 | Qatanani Mo — Chief Scientific Officer | Grant/award (A): 29,258 @ $0 | EDGAR |
| 2026-02-11 | 4 | Parlavecchio Caryn — Chief Human Resources Officer | Grant/award (A): 29,258 @ $0 | EDGAR |
| 2026-02-11 | 4 | Marantz Jing L. — Chief Medical Officer | Grant/award (A): 34,482 @ $0 | EDGAR |
| 2026-02-11 | 4 | Ho Junlin — General Counsel | Grant/award (A): 36,572 @ $0 | EDGAR |
| 2026-02-11 | 4 | Woods Keith — Chief Operating Officer | Grant/award (A): 47,021 @ $0 | EDGAR |
| 2026-02-11 | 4 | Vaishnaw Akshay — President of R&D, Director | Grant/award (A): 47,021 @ $0 | EDGAR |
| 2026-02-11 | 4 | Hallal David — Chief Executive Officer, Director | Grant/award (A): 128,004 @ $0 | EDGAR |
| 2026-02-11 | 4 | Sinha Vikas — Chief Financial Officer | Grant/award (A): 47,021 @ $0 | EDGAR |
| 2026-02-06 | 4 | Invus Global Management, LLC — 10% owner Siren, L.L.C. — 10% owner DEBBANE RAYMOND — 10% owner | Option exercise/expiry (X): 1,575,008 @ $7.35 · Option exercise/expiry (X): 1,575,008 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Sale (S): 2,119 @ $45.87 · Sale (S): 12,779 @ $46.85 | EDGAR |
| 2026-01-21 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Sale (S): 8,406 @ $44.48 | EDGAR |
| 2026-01-21 | 4 | Parlavecchio Caryn — CHRO | Sale (S): 6,600 @ $44.48 | EDGAR |
| 2026-01-21 | 4 | Ho Junlin — GENERAL COUNSEL | Sale (S): 8,016 @ $44.48 | EDGAR |
| 2026-01-21 | 4 | Marantz Jing L. — CHIEF MEDICAL OFFICER | Sale (S): 5,798 @ $44.48 | EDGAR |
| 2026-01-16 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 1,407 @ $18.08 · Option exercise (M): 321 @ $7.62 · Option exercise (M): 2,813 @ $10 · Option exercise (M): 5,893 @ $15.75 · Option exercise (M): 2,678 @ $35.15 · Sale (S): 13,112 @ $45.20 · +5 more | EDGAR |
| 2026-01-15 | 4 | Woods Keith — Chief Operating Officer | Sale (S): 16,746 @ $42.70 | EDGAR |
| 2026-01-15 | 4 | Vaishnaw Akshay — President of R&D, Director | Sale (S): 20,438 @ $42.70 | EDGAR |
| 2026-01-15 | 4 | Hallal David — Chief Executive Officer, Director | Sale (S): 57,450 @ $42.70 | EDGAR |
| 2026-01-15 | 4 | Sinha Vikas — Chief Financial Officer | Sale (S): 16,755 @ $42.70 | EDGAR |
| 2025-12-18 | 4 | Peng Katie — Director | Sale (S): 726 @ $43.88 · Sale (S): 280 @ $44.63 | EDGAR |
| 2025-12-16 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 12,796 @ $39.31 · Purchase (P): 12,400 @ $40.18 · Purchase (P): 4,403 @ $40.97 · Option exercise/expiry (X): 1,064,804 @ $7.35 · Option exercise/expiry (X): 1,064,804 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 65,625 @ $26.05 · Option exercise (M): 21,093 @ $18.08 · Option exercise (M): 5,607 @ $4.86 · Option exercise (M): 1,281 @ $7.62 · Option exercise (M): 11,250 @ $10 · Option exercise (M): 23,571 @ $15.75 · +9 more | EDGAR |
| 2025-10-09 | 4 | Hallal David — Chief Executive Officer, Director | Gift (G): 205,000 @ $0 | EDGAR |
| 2025-10-07 | 4 | AKKARAJU SRINIVAS — Director | Purchase (P): 11,011 @ $35.61 · Purchase (P): 56,703 @ $36.74 · Purchase (P): 319,700 @ $37.42 · Purchase (P): 18,414 @ $37.89 · Purchase (P): 80,863 @ $38.68 · Purchase (P): 13,748 @ $39.52 | EDGAR |
| 2025-09-24 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Sale (S): 3,353 @ $30.67 | EDGAR |
| 2025-09-17 | 4 | Peng Katie — Director | Sale (S): 930 @ $32.48 · Sale (S): 76 @ $33.20 | EDGAR |
| 2025-09-17 | 4 | Qatanani Mo — CHIEF SCIENTIFIC OFFICER | Sale (S): 3,178 @ $33.52 | EDGAR |
| 2025-08-19 | 4 | Parlavecchio Caryn — CHRO | Sale (S): 2,178 @ $31.17 | EDGAR |
Recent 8-K events — Scholar Rock Holding Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-06-05 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K/A | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SRRK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →